I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Projects
FAIRness for Life Science Data in Austria
Ecker, G. (Project Lead)
1/06/17 → 31/12/19
Project: Research funding
eTRANSAFE: Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management
Ecker, G. (Project Lead), Dangl, A. (Admin), Hemmerich, J. (Scientific Project Staff), Smajic, A. (Scientific Project Staff), Grandits, M. (Scientific Project Staff), Kaiser, F. (Scientific Project Staff) & Schwarzenböck, M. (Project Staff)
1/09/17 → 28/02/23
Project: Research funding
ReSOLUTE: Research Empowerment on Solute Carriers
Ecker, G. (Project Lead), Dangl, A. (Admin), Digles, D. (Scientific Project Staff), Colas, C. (Scientific Project Staff) & Schwarzenböck, M. (Project Staff)
1/07/18 → 31/12/23
Project: Research funding
Add medical genetic solutions to RESOLUTE
Ecker, G. (Project Lead), Dangl, A. (Admin), Colas, C. (Scientific Project Staff), Huang, J. (Scientific Project Staff), Digles, D. (Scientific Project Staff) & Schwarzenböck, M. (Admin)
1/06/21 → 31/05/23
Project: Research funding
RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs
Ecker, G. (Project Lead), Dangl, A. (Admin) & Schwarzenböck, M. (Project Staff)
1/06/21 → 31/05/26
Project: Research funding